How a Twitter hashtag provides support for people with breast cancer

October 23, 2020

A UCLA-led review of nine years of social media posts with the hashtag #BCSM suggests that Twitter can be a useful resource not only for patients, but also for physicians and researchers.

The hashtag -- an initialism for "breast cancer social media" -- first appeared on Twitter in 2011. Created by two cancer survivors, it was used to curate a weekly informational chat for people with breast cancer. Dr. Deanna Attai became one of the group's moderators a few weeks later.

"We physicians have a lot to learn from the online patient communities," said Attai, an assistant clinical professor of surgery at the David Geffen School of Medicine at UCLA, and the lead author of the study. "Tapping into this gold mine of experience will ensure that when we design research studies, we are asking questions that are actually relevant and important to patients."

The research found that, between Jan. 1, 2011, and Jan. 1, 2020, #BCSM was used more than 830,000 times by more than 75,000 unique Twitter accounts, generating 4 billion impressions. The hashtag was used 145,600 times in 2019 alone, an increase of 424% from 2011 when it appeared 27,700 times.

The study, published today in the Journal of Patient-Centered Research and Reviews, is intended to help researchers understand the impact of the community that grew up around the Twitter chat. It reveals that, paralleling the rise of social media in everyday life, the growing popularity of #BCSM demonstrated that an increasing number of people with breast cancer are turning to online communities for support and education.

#BCSM has evolved into much more than a hook for weekly virtual meetings. The hashtag made it easy for people with breast cancer to find support and useful content -- and for their family members, patient advocates, physicians, researchers, journalists and others to source good information.

"The #BCSM online community has experienced tremendous growth since its inception because it has helped fulfill a need among patients who were searching for information and support on the platform," said Attai, who is also a member of the UCLA Jonsson Comprehensive Cancer Center. "But it has also helped us physicians gain insight into the patient perspective and has given us a better understanding of their many issues. We often see patients in a much different setting. Compared to our exam room interactions, online is a more raw, unvarnished look into what patients are really going through."

The platform also gave professionals the opportunity to, in real time, correct misconceptions, provide guidance to people with breast cancer and steer them toward credible resources, Attai said.

To compile data on the use of #BCSM, the researchers used Symplur, a health care-focused analytics program commonly used to study trends on Twitter.

The research also found that number of health care professionals, including doctors, who use the hashtag has grown significantly, from 96 by the end of 2011 to more than 3,000 in 2019.

The study notes that the inclusive nature of the #BCSM hashtag -- it's not restricted by gender or by people's stage of diagnosis -- has probably contributed to its popularity. But its breadth might also limit how sustainable the online community will be, because as cancer therapy continues to become more personalized, people may increasingly seek out support groups that are more closely aligned with their own clinical situations.
The study's other authors are Dr. Matthew Katz of Lowell General Hospital in Massachusetts and Alicia Staley of Medidata, a New York-based life sciences technology company.

University of California - Los Angeles Health Sciences

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to